New initiation of opioids, benzodiazepines and antipsychotics following hospitalization for COVID‐19

Samantha Harrison(Beth Israel Deaconess Medical Center), Somnath Bose(Prime University), Akiva Leibowitz(Beth Israel Deaconess Medical Center), Ji Liu(Beth Israel Deaconess Medical Center), Krystal Capers(Beth Israel Deaconess Medical Center), Valerie Banner‐Goodspeed(Beth Israel Deaconess Medical Center), Ameeka Pannu, Guanqing Chen(Beth Israel Deaconess Medical Center)
Journal of Hospital Medicine
May 14, 2024
10.1002/jhm.13408
Cited by 0

Related Papers

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555
Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure–Guided Strategy vs an Empirical High PEEP-F <scp>io</scp> <sub>2</sub> Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome
|JAMA|2019|468
Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition
|American Journal of Respiratory and Critical Care Medicine|2015|454
Effect of Intravenous Acetaminophen vs Placebo Combined With Propofol or Dexmedetomidine on Postoperative Delirium Among Older Patients Following Cardiac Surgery
|JAMA|2019|322